A reduction in price target typically indicates a change in the expected future performance of a company. Although the Overweight rating suggests that Keybanc still sees positive prospects for Avid Bioservices, the lowered price target may lead to short-term negative sentiment among investors, potentially causing a decrease in the stock price.